Andrea Van Beek Invites You to Join The 2025 Virtual Boot Camp
Andrea Van Beek, Board of Directors of Anticoagulation Forum, National Certification Board for Anticoagulation Providers, shared an inviing post on LinkedIn:
”Want to expand your knowledge about all-things anticoagulation – all from the comfort of your couch?!
Join us for our (very popular!) 2 day virtual Boot Camp this fall!
I’ll be giving talks about Warfarin day-to-day management (including some difficult warfarin cases), as well as Shared Decision Making and Patient Education.
You won’t want to miss our daily Chalk Talks – ask the experts all your burning questions.
Register today to reserve your spot!
The 2025 Virtual Boot Camp is now open for registration.
This trusted, expert-led program returns October 17–18 with fresh topics, real-world insights, and 30 days of enduring access to fit any schedule.”
Anticoagulation Forum shared a post on LinkedIn:
‘The 2025 Boot Camp offers:
Comprehensive curriculum covering anticoagulation, disease state, and drug management
Interactive “Chalk Talks” and live Q and As with expert faculty
Designed for pharmacists, physicians, nurses, and trainees
Earn valuable CE credits and practical strategies to bring back to your practice
The registration rate is USD349 for all registrants, and it will remain open until October 18, 2025. Group pricing is available; email [email protected] to inquire.
Whether you are training new clinicians or refreshing your own knowledge, this is a must-attend event for staying current and connected.’
Andrea Van Beek shared an invitation you should not miss. Register Now.
Learn about all the opportunities in the field with Hemostasis Today.
-
Nov 3, 2025, 08:23The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
-
Nov 3, 2025, 08:15Bert van Meurs Shares the New Late-breaking Results from the iMODERN Trial
-
Nov 3, 2025, 07:10Lisa Shea Shares Key Takeaways from NORD Summit 2025
-
Nov 3, 2025, 06:49Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 3, 2025, 04:56Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 3, 2025, 09:24Stephen Cornelissen: It’s Not Just About Emergencies — It’s About Everyday Care, Chronic Conditions and Hope
-
Nov 3, 2025, 06:57Maria Elisa Mancuso Reflects on 2025 Annual Congress of the Italian Association of Hemophilia Centres
-
Nov 3, 2025, 05:46Chandra Viswanathan: When Blood Safety Fails, We All Bleed - A Call for Reform and Responsibility
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry